Correlation Between Edgewise Therapeutics and Third Harmonic
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Third Harmonic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Third Harmonic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Third Harmonic Bio, you can compare the effects of market volatilities on Edgewise Therapeutics and Third Harmonic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Third Harmonic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Third Harmonic.
Diversification Opportunities for Edgewise Therapeutics and Third Harmonic
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Edgewise and Third is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Third Harmonic Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Third Harmonic Bio and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Third Harmonic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Third Harmonic Bio has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Third Harmonic go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Third Harmonic
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Third Harmonic. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.54 times less risky than Third Harmonic. The stock trades about -0.12 of its potential returns per unit of risk. The Third Harmonic Bio is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,307 in Third Harmonic Bio on August 25, 2024 and sell it today you would lose (60.00) from holding Third Harmonic Bio or give up 4.59% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.65% |
Values | Daily Returns |
Edgewise Therapeutics vs. Third Harmonic Bio
Performance |
Timeline |
Edgewise Therapeutics |
Third Harmonic Bio |
Edgewise Therapeutics and Third Harmonic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Third Harmonic
The main advantage of trading using opposite Edgewise Therapeutics and Third Harmonic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Third Harmonic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will offset losses from the drop in Third Harmonic's long position.Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Third Harmonic vs. Ikena Oncology | Third Harmonic vs. Eliem Therapeutics | Third Harmonic vs. HCW Biologics | Third Harmonic vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |